πŸ“‹ Affiliate Disclosure: Paragon Health Access is operated by Paragon Frontier Capital LLC and earns commissions when readers enroll in programs through our links. This never affects our editorial assessments. Programs receiving FDA warning letters are not featured. This article is for informational purposes only and does not constitute medical advice.

What Happened β€” and Why It Matters for Your Choice

In March 2026, the FDA sent warning letters to 30 telehealth companies selling compounded semaglutide and tirzepatide. The primary violations cited: claiming compounded versions were equivalent to branded FDA-approved drugs, and continuing to mass-compound after the shortage designation ended.

This wasn't a surprise to anyone watching the space. The FDA had been escalating enforcement since early 2025. What changed in 2026 is the speed and scope β€” and the fact that several major platforms that built their entire business on compounded GLP-1s were suddenly forced to pivot or shut down.

⚠️ If your current program received an FDA warning letter: This does not necessarily mean the program is shutting down β€” but it does mean they were found to be out of compliance. Ask your provider directly what changes they are making and whether your medication supply is at risk.

Our Criteria for This Guide

Every program featured in this guide was evaluated against four criteria. We do not feature programs that fail any one of them:

βš•οΈ
Licensed Physicians
All prescriptions written by licensed US healthcare providers β€” not rubber-stamp approvals
πŸ›οΈ
No Active FDA Action
No outstanding FDA warning letters or active enforcement actions as of our last review
πŸ’Š
FDA-Authorized Medications
Programs offering FDA-approved branded medications or operating within current legal compounding frameworks
πŸ’°
Transparent Pricing
Pricing disclosed before enrollment β€” no hidden fees revealed after signup
πŸ—ΊοΈ
Clear State Coverage
Explicit about which states they serve β€” not vague "most states" language
πŸ“‹
Honest Marketing
No exaggerated weight loss claims, no fake testimonials, no misleading comparisons to branded drugs

Programs We Recommend in 2026

Enhance MD
Physician-Led GLP-1 & GIP-GLP-1 β€” All-Inclusive Pricing
βœ“ No FDA Action

Enhance MD takes a physician-first approach to GLP-1 weight loss β€” combining comprehensive lab testing, personalized dosing protocols, and transparent all-inclusive pricing. Their model covers both GLP-1 and GIP-GLP-1 medications with full physician oversight on every prescription. Pricing is disclosed upfront with no hidden fees revealed after enrollment.

Strengths

  • βœ“ Physician-led protocols β€” not algorithm-driven
  • βœ“ Comprehensive lab testing included
  • βœ“ Transparent all-inclusive pricing
  • βœ“ Both GLP-1 and GIP-GLP-1 options
  • βœ“ No hidden fees or surprise charges

Considerations

  • β†’ Lab testing requirement adds time to onboarding
  • β†’ Not the lowest entry price point
  • β†’ Best suited for patients wanting full medical oversight

Best for: Patients who want a comprehensive, physician-supervised GLP-1 program with full lab work and transparent pricing.

View Program β†’
Direct Meds
GLP-1 Telehealth β€” Streamlined Intake
βœ“ No FDA Action

Direct Meds is a performance-optimized GLP-1 telehealth platform designed for speed and simplicity. Their intake process is among the most streamlined in the space β€” connecting patients with licensed physicians quickly and efficiently. The program is built for long-term patient success with nationwide provider coverage.

Strengths

  • βœ“ Fast streamlined intake process
  • βœ“ Licensed physicians nationwide
  • βœ“ Designed for long-term patient success
  • βœ“ Direct-to-door medication delivery
  • βœ“ Strong compliance posture

Considerations

  • β†’ Less comprehensive than full-service programs
  • β†’ Best for patients who want a simple fast process
  • β†’ Verify current medication options before enrolling

Best for: Patients who want a fast, simple GLP-1 telehealth process without lengthy onboarding.

View Program β†’
SkinnyRx
GLP-1 Telehealth β€” Nationwide Coverage
⚠ Monitor Compliance

SkinnyRx offers GLP-1 weight loss programs through licensed physicians with fast online intake and direct-to-door delivery. They have broad nationwide coverage and a straightforward enrollment process. As with all programs in this space, we recommend verifying their current medication sourcing and compliance status before enrolling given the ongoing FDA enforcement environment.

Strengths

  • βœ“ Fast online intake and approval
  • βœ“ Licensed providers nationwide
  • βœ“ Direct-to-door delivery
  • βœ“ Straightforward enrollment process
  • βœ“ Broad state coverage

Considerations

  • β†’ Verify current medication sourcing given FDA environment
  • β†’ Confirm pricing transparency before submitting payment
  • β†’ Monitor their compliance standing as regulations evolve

Best for: Patients looking for fast access to GLP-1 programs with broad state availability β€” verify compliance status before enrolling.

View Program β†’
Sprout Health
GLP-1 Telehealth β€” Physician Oversight
βœ“ No FDA Action

Sprout Health offers a streamlined GLP-1 telehealth model built around physician oversight on every prescription. Their platform connects patients with licensed providers quickly while maintaining medical integrity throughout the process. Nationwide provider access and direct delivery make them a practical choice for most US patients.

Strengths

  • βœ“ Physician oversight on every prescription
  • βœ“ Streamlined patient intake
  • βœ“ Licensed providers nationwide
  • βœ“ Direct-to-door medication delivery
  • βœ“ Clean compliance profile

Considerations

  • β†’ Newer platform β€” less established track record than some competitors
  • β†’ Verify current program pricing before enrolling
  • β†’ Confirm state availability for your specific location

Best for: Patients who want a clean, physician-supervised GLP-1 program with a straightforward enrollment process.

View Program β†’

Programs We Are Watching β€” Not Currently Featured

These programs are in our monitoring list. We are not currently featuring them as affiliate partners due to outstanding compliance questions or pending review:

⚠️ Red flags to watch for: Any program claiming their compounded medication is "the same as" Wegovy or Ozempic, hiding pricing until after enrollment, not disclosing their pharmacy's compounding status, or offering prices dramatically lower than branded alternatives without explanation deserves careful scrutiny in the current environment.

How to Choose the Right Program for You

With the regulatory landscape now clearer, here is a simple framework for choosing a GLP-1 telehealth program in 2026:

  1. Confirm the medication type β€” Are they offering FDA-approved branded medications or compounded alternatives? If compounded, ask specifically which pharmacy pathway (503A patient-specific vs 503B bulk) and whether there is documented clinical justification.
  2. Check for FDA warning letters β€” Search "[provider name] FDA warning letter 2026" before enrolling. This is public information.
  3. Verify state availability β€” Confirm your state is explicitly listed, not implied by "most states" language.
  4. Review the pricing before giving your card details β€” Any program that won't show you full pricing before enrollment is a yellow flag.
  5. Confirm physician involvement β€” A licensed physician should review your health history and make the prescribing decision β€” not an algorithm.

Compare Vetted GLP-1 Providers

All programs in our directory β€” Enhance MD, Direct Meds, SkinnyRx, and Sprout Health β€” are reviewed for FDA compliance, pricing transparency, and physician quality. Updated May 2026.

View Provider Directory β†’

This article is for informational purposes only and does not constitute medical advice. Provider information is reviewed regularly but may change β€” verify current program details directly with each provider before enrolling. Last reviewed: May 2026. Sources: FDA.gov, Pharmacy Times, Federal Register, company announcements.